APG Asset Management’s AstraZeneca AZN Stock Holding History

APG Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-144,050	Closed	-$19.5M	–	725
2023 Q3	$19.5M	Sell	144,050 -42,500	-23%	-$5.8M	0.04%	327
2023 Q2	$24.5M	Buy	186,550 +35,700	+24%	+$5.25M	0.05%	311
2023 Q1	$19.3M	Buy	150,850 +5,500	+4%	+$740K	0.04%	356
2022 Q4	$19.7M	Buy	+145,350	New	+$18.2M	0.04%	376
2022 Q2	–	Sell	-43,569	Closed	-$5.2M	–	877
2022 Q1	$5.2M	Buy	+43,569	New	+$5.22M	0.01%	461

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

APG Asset Management's AZN Position: Q4 2023 in Review

APG Asset Management sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 144,050 shares — an estimated $19.5M sold.

APG Asset Management first reported a position in AZN in Q1 2022 and held it in 5 quarters. The position peaked at $24.5M in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

APG Asset Management reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
APG Asset Management sold 144,050 AstraZeneca shares in Q4 2023, an estimated $19.5M.
APG Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 5 quarters.
APG Asset Management's AstraZeneca position peaked at $24.5M in Q2 2023.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on APG Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.